Nine Square Therapeutics
Jacob Eriksen has a diverse work experience in the scientific and research field. Jacob currently holds the position of Senior Scientist at Nine Square Therapeutics, starting in January 2022. Prior to this, they worked as a Post-doctoral fellow at UCSF from October 2011 to December 2021. Jacob also has experience working at the University of Copenhagen, where they held multiple roles, including Post Doc from December 2009 to October 2011, Ph.D. student from November 2006 to December 2009, and Research Assistant from April 2005 to November 2006.
Jacob Eriksen completed their high school education at Hasseris Gymnasium from 1994 to 1997. Jacob then pursued a Cand. Scient. degree in Human Biology at Københavns Universitet - University of Copenhagen from 1999 to 2005. In 2007, Eriksen enrolled in the same university to earn a PhD in Neuroscience, which they completed in 2010.
This person is not in any offices
Nine Square Therapeutics
Nine Square Therapeutics is discovering new small-molecule therapeutics for degenerative movement disorders including Parkinson’s disease and amyotrophic lateral sclerosis (ALS), as well as non-degenerative disorders such as essential tremor and dyskinesias, by integrating computational chemistry, biophysics, and computational biology intomachine-learning-enabled cell profiling platforms for target identification, chemical optimization, and patient stratification.It was founded in 2020 and headquartered in New York, United States.